BLFS Q3 2018 Earnings — BioLife Solutions, Inc. Revenue & Financial Results | Market Cap Arena

BLFSBioLife Solutions, Inc.

$890M

Q3 2018 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$5M+78.6% YoY

Gross Profit

$4M69.7% margin

Operating Income

$1M22.6% margin

Net Income

$1M23.3% margin

EPS (Diluted)

$0.05

QoQ Revenue Growth

+2.2%

Cash Flow

Operating Cash Flow

$809,205

Free Cash Flow

$531,616

Stock-Based Comp.

$383,140

Balance Sheet

Total Assets

$46M

Total Liabilities

$3M

Stockholders' Equity

$44M

Cash & Equivalents

$32M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$3M	+78.6%
Gross Profit	$4M	$2M	+97.4%
Operating Income	$1M	-$32,345	+3794.5%
Net Income	$1M	-$318,718	+486.2%